Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00159614 | Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment | PHASE2 | COMPLETED | 30 | — | — | Sep 1, 2005 | - | Jan 29, 2008 | 6 | United States |
| NCT00159627 | Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF). | PHASE2 | COMPLETED | 52 | — | — | Aug 1, 2004 | - | Jan 29, 2008 | 10 | United States |
| Name | Type | Description |
|---|---|---|
| KW-3902IV | DRUG | - |
Inclusion Criteria: * Stable congestive heart failure * Impaired renal function * Taking oral loop diuretic Exclusion Criteria: * Acutely decompensated (unstable) and end stage heart failure * Diuretics other than loop diuretics * Pregnant or nursing * Inability to follow instructions * Participa...